Literature DB >> 16804535

CIMPle origin for promoter hypermethylation in colorectal cancer?

Kornel Schuebel, Wei Chen, Stephen B Baylin.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16804535     DOI： 10.1038/ng0706-738

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

1.  Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.

Authors:  Toshinori Hinoue; Daniel J Weisenberger; Fei Pan; Mihaela Campan; Myungjin Kim; Joanne Young; Vicki L Whitehall; Barbara A Leggett; Peter W Laird
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

2.  The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.

Authors:  Shan Muhammad; Zheng Jiang; Zheng Liu; Kavanjit Kaur; Xishan Wang
Journal:  J Gastrointest Oncol       Date:  2013-03

Review 3.  Tumor-initiating and -propagating cells: cells that we would like to identify and control.

Authors:  Berit Bølge Tysnes
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

Review 4.  EZH2: not EZHY (easy) to deal.

Authors:  Gauri Deb; Anup Kumar Singh; Sanjay Gupta
Journal:  Mol Cancer Res       Date:  2014-02-13       Impact factor: 5.852

5.  Molecular mechanism of SLC5A8 inactivation in breast cancer.

Authors:  Selvakumar Elangovan; Rajneesh Pathania; Sabarish Ramachandran; Sudha Ananth; Ravi N Padia; Sonne R Srinivas; Ellappan Babu; Lesleyann Hawthorn; Patricia V Schoenlein; Thomas Boettger; Sylvia B Smith; Puttur D Prasad; Vadivel Ganapathy; Muthusamy Thangaraju
Journal:  Mol Cell Biol       Date:  2013-08-05       Impact factor: 4.272

6.  Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.

Authors:  Karen Curtin; Martha L Slattery; Cornelia M Ulrich; Jeannette Bigler; Theodore R Levin; Roger K Wolff; Hans Albertsen; John D Potter; Wade S Samowitz
Journal:  Carcinogenesis       Date:  2007-04-21       Impact factor: 4.944

Review 7.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.

Authors:  Helena Carén; Steven M Pollard; Stephan Beck
Journal:  Mol Aspects Med       Date:  2012-07-04

8.  Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.

Authors:  Simona Baronchelli; Angela Bentivegna; Serena Redaelli; Gabriele Riva; Valentina Butta; Laura Paoletta; Giuseppe Isimbaldi; Monica Miozzo; Silvia Tabano; Antonio Daga; Daniela Marubbi; Monica Cattaneo; Ida Biunno; Leda Dalprà
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Array-based DNA methylation profiling in follicular lymphoma.

Authors:  C O'Riain; D M O'Shea; Y Yang; R Le Dieu; J G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; C A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; L M Rimsza; E B Smeland; W C Chan; N Johnson; R D Gascoyne; S Reimer; R M Braziel; G W Wright; L M Staudt; T A Lister; J Fitzgibbon
Journal:  Leukemia       Date:  2009-07-09       Impact factor: 11.528

Review 10.  The mammary cellular hierarchy and breast cancer.

Authors:  Samantha R Oakes; David Gallego-Ortega; Christopher J Ormandy
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.